IntegenX Acquires GenVault, Raises $15.6M | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – Sample preparation firm IntegenX today said that it has acquired biosample storage firm GenVault. It also announced it has raised $15.6 million in a financing round.

Stevan Jovanovich, president and CEO of IntegenX, declined to disclose the terms of the deal but said the purchase moves the company further upstream in the sequencing market.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: nanopore sequencing workflow to detect antibiotic resistance in gut microbes, TSSPlant tool, and more.

Because gene-edited organisms can cross borders, Gizmodo wonders whether there should be an international body to govern their use.

HHS Secretary nominee Tom Price is to go in front of the Senate Committee on Health, Education, Labor and Pensions today, NPR's Morning Edition reports.

Prior to being closed, Theranos' Arizona lab failed an inspection by regulators, according to the Wall Street Journal.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.